22NW LP’s Meridian Bioscience Inc VIVO Stock Holding History

22NW LP’s Portfolio VIVO Stock Details VIVO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q2	–	Sell	-70,303	Closed	-$591K	–	111
2020 Q1	$591K	Buy	+70,303	New	+$592K	0.46%	72

Other funds holding VIVO

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Fuller & Thaler Asset Management San Mateo, California $29.7B AUM 43.33% 1-Year Est. Return

Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

SFM

Systematic Financial Management Teaneck, New Jersey $4.36B AUM 40.56% 1-Year Est. Return

22NW LP's VIVO Position: Q2 2020 in Review

22NW LP sold out of Meridian Bioscience Inc (VIVO) in Q2 2020, closing a stake of 70,303 shares — an estimated $591K sold.

22NW LP first reported a position in VIVO in Q1 2020 and held it in 1 quarter. The position peaked at $591K in Q1 2020. 191 funds tracked by Wall St. Rank hold VIVO as of Q2 2020.

22NW LP reported no remaining Meridian Bioscience Inc position as of Q2 2020 after selling out during the quarter.
22NW LP sold 70,303 Meridian Bioscience Inc shares in Q2 2020, an estimated $591K.
22NW LP first reported a position in Meridian Bioscience Inc in Q1 2020 and held it in 1 quarter.
22NW LP's Meridian Bioscience Inc position peaked at $591K in Q1 2020.
191 funds tracked by Wall St. Rank held Meridian Bioscience Inc as of Q2 2020.

Based on 22NW LP's 13F filing for Q2 2020, filed 14 Aug 2020.